side effects tirzepatide vs semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide and Semaglutide: Safety, Science,

Based on the groups findings, The Obesity Society, American College of Lifestyle Medicine, American Society for Nutrition, and the Obesity Medicine Association simultaneously published Nutritional Priorities to Support GLP-1 Therapy for Obesity in their own peer-reviewed journals

Additionally, some studies suggest potential benefits for individuals with autism spectrum disorder (ASD), including improved processing of social information and enhanced social skills

Not all symptoms are readily apparent

J Pept Sci 17:270280 Bianchi E, Carrington PE, Ingallinella P et al (2013) A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity

Patients with histories of particular thyroid conditions, pancreatitis, or severe gastrointestinal issues should discuss other options with their provider

Get prior authorization : Providers on Klarity Health can help you get the right documents to secure approval